Biolite, Inc.
Clinical trials sponsored by Biolite, Inc., explained in plain language.
-
New combo aims to cut infections in bone marrow cancer
Disease control Not yet recruitingThis study tests a new oral liquid drug, BLEX 404, combined with a standard chemotherapy (azacitidine) for people with certain types of bone marrow cancers (MDS and CMML). The goal is to find a safe dose and see if it can reduce serious infections. About 52 adults who have not be…
Phase: PHASE2 • Sponsor: BioLite, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo therapy targets tough breast cancer
Disease control Not yet recruitingThis study is for people with advanced triple negative breast cancer, a type that is harder to treat. It tests a new oral liquid drug called BLEX 404 given with the chemotherapy drug Docetaxel. The goal is to find a safe dose and see if the combination helps shrink tumors. About …
Phase: PHASE1, PHASE2 • Sponsor: BioLite, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New pill hopes to lift mood in cancer patients
Symptom relief Not yet recruitingThis study tests a new drug called PDC-1421 to see if it is safe and helps with depression in people who have cancer. About 12 adults with mild to severe depression and stage I-III cancer will take the drug for up to 5 weeks. Doctors will check mood changes using a standard depre…
Phase: PHASE1, PHASE2 • Sponsor: BioLite, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC